Towards a Treatment for Gulf War Illness: A Consensus Docking Approach

Area of Science:

• Computational chemistry and pharmacology
• Neuroscience and immunology

Background:

• Gulf War Illness (GWI) affects veterans exposed to neurotoxicants and stress, with no known cure.
• Existing treatment strategies involve targeting interleukin-2, tumor necrosis factor alpha, and the glucocorticoid receptor.
• Pharmaceutical development is hindered by potential off-target drug effects.

Purpose of the Study:

• To identify FDA-approved pharmaceuticals for GWI treatment using computational docking.
• To screen drugs against immune and stress targets relevant to GWI.
• To assess potential off-target interactions with androgen and estrogen targets.

Main Methods:

• Consensus docking using AutoDock 4.2, AutoDock Vina, and Schrodinger's Glide.
• Screening of FDA-approved pharmaceuticals against GWI-related immune and hormonal targets.
• Evaluation of binding affinities and specificity to avoid off-target effects.

Main Results:

• Suramin demonstrated high affinity for immune targets.
• Top binders for hormonal and glucocorticoid targets showed non-specific binding, potentially due to protein structural similarities.

Conclusions:

• The interplay between immune and hormonal systems complicates GWI drug development.
• Further understanding of these interactions is crucial for developing effective GWI therapies.